Weinstock-Guttman B - Search Results

1

Comment on "no evidence of chronic cerebrospinal venous insufficiency at multiple sclerosis onset".

Zivadinov R, Ramanathan M, Dwyer MG, Marr K, Benedict RH, Weinstock-Guttman B. Zivadinov R, et al. Ann Neurol. 2011 Jun;69(6):1062-3; author reply 1063. doi: 10.1002/ana.22420. Ann Neurol. 2011. PMID: 21681801 No abstract available.

2

The interferons: biological effects, mechanisms of action, and use in multiple sclerosis.

Weinstock-Guttman B, Ransohoff RM, Kinkel RP, Rudick RA. Weinstock-Guttman B, et al. Ann Neurol. 1995 Jan;37(1):7-15. doi: 10.1002/ana.410370105. Ann Neurol. 1995. PMID: 7529476 Review. No abstract available.

3

A phase II study of i.v. methylprednisolone in secondary-progressive multiple sclerosis.

Goodkin DE, Kinkel RP, Weinstock-Guttman B, VanderBrug-Medendorp S, Secic M, Gogol D, Perryman JE, Uccelli MM, Neilley L. Goodkin DE, et al. Neurology. 1998 Jul;51(1):239-45. doi: 10.1212/wnl.51.1.239. Neurology. 1998. PMID: 9674809 Clinical Trial.

4

Use of the Multiple Sclerosis Functional Composite to predict disability in relapsing MS.

Rudick RA, Cutter G, Baier M, Fisher E, Dougherty D, Weinstock-Guttman B, Mass MK, Miller D, Simonian NA. Rudick RA, et al. Neurology. 2001 May 22;56(10):1324-30. doi: 10.1212/wnl.56.10.1324. Neurology. 2001. PMID: 11376182

5

Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden.

Benedict RH, Weinstock-Guttman B, Fishman I, Sharma J, Tjoa CW, Bakshi R. Benedict RH, et al. Arch Neurol. 2004 Feb;61(2):226-30. doi: 10.1001/archneur.61.2.226. Arch Neurol. 2004. PMID: 14967771 Clinical Trial.

6

Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis.

Cree BA, Khan O, Bourdette D, Goodin DS, Cohen JA, Marrie RA, Glidden D, Weinstock-Guttman B, Reich D, Patterson N, Haines JL, Pericak-Vance M, DeLoa C, Oksenberg JR, Hauser SL. Cree BA, et al. Neurology. 2004 Dec 14;63(11):2039-45. doi: 10.1212/01.wnl.0000145762.60562.5d. Neurology. 2004. PMID: 15596747

7

Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity.

Bermel RA, Puli SR, Rudick RA, Weinstock-Guttman B, Fisher E, Munschauer FE 3rd, Bakshi R. Bermel RA, et al. Arch Neurol. 2005 Sep;62(9):1371-6. doi: 10.1001/archneur.62.9.1371. Arch Neurol. 2005. PMID: 16157744 Free PMC article.

8

Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis.

Sanfilipo MP, Benedict RH, Weinstock-Guttman B, Bakshi R. Sanfilipo MP, et al. Neurology. 2006 Mar 14;66(5):685-92. doi: 10.1212/01.wnl.0000201238.93586.d9. Neurology. 2006. PMID: 16534104

9

Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis.

Benedict RH, Bruce JM, Dwyer MG, Abdelrahman N, Hussein S, Weinstock-Guttman B, Garg N, Munschauer F, Zivadinov R. Benedict RH, et al. Arch Neurol. 2006 Sep;63(9):1301-6. doi: 10.1001/archneur.63.9.1301. Arch Neurol. 2006. PMID: 16966509

10

Interferon inhibitory activity in patients with multiple sclerosis.

Chadha K, Weinstock-Guttman B, Zivadinov R, Bhasi K, Muhitch J, Feichter J, Tamaño-Blanco M, Abdelrahman N, Ambrus J Sr, Munschauer F, Ramanathan M. Chadha K, et al. Arch Neurol. 2006 Nov;63(11):1579-84. doi: 10.1001/archneur.63.11.1579. Arch Neurol. 2006. PMID: 17101826

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results